{u'keywords': [u'mr narain', u'Stock Exchange', u'financial product', u'CIL', u'relation', u'Citrofresh', u'letter', u'emergency disease control', u'professor wesselingh', u'financial service', u'commission', u'post intercourse', u'HIV', u'Mr Taylor', u'Mr Wright', u'mr narain engage', u'postcoital application', u'Mr Ravi Narain', u'statement', u'human immunodeficiency virus', u'global solution', u'email Mr Narain', u'human rhinovirus', u'post intercourse spray', u'grounds Mr Narain', u'Stock Exchange CIL', u'conduct', u'Stranded RNA Virus', u'human influenza', u'CIL shares', u'Act', u'Reference Laboratory Foundation', u'Rickettsial Reference Laboratory', u'Exchange CIL shares', u'announcement', u'Australian Rickettsial Reference', u'retroscreen report', u'sars virus', u'effective solution', u'Stamp Duties', u'market', u'CIL share price', u'significant impact', u'Single Stranded RNA', u'products', u'relationship', u'Technical Products Pty', u'Mr Sam Taylor', u'reasonable grounds', u'Mr Hanlon'], u'casename': u'Australian Securities amp; Investments Commission v Citrofresh International Ltd (ACN 064 551 426) [2007] FCA 1873 (30 November 2007)', u'filename': u'training_data/07_1873.xml'}